This brand name is authorized in Nigeria.
The drug PROGERIX contains one active pharmaceutical ingredient (API):
1
|
UNII
90I02KLE8K - DYDROGESTERONE
|
Dydrogesterone is an orally-active progestogen having an activity comparable to parenterally administered progesterone. |
|
This drug has been approved in Nigeria as follows:
Identifier | Form | Presentation | Description | Approval |
---|---|---|---|---|
A4-100399 | Tablet | PROGERIX Tablet TAB 10 mg 2 X 15 | 131 NF-PP-261232 PROGERIX Tablet DYDROGESTERONE DYDROGESTERONE 10MG, MAIZE STARCH, MICROCRYSTALLINE CELLULOSE Drugs Imported Products 2X15 Prescription Only Medicine (POM) 4/27/2022 GENERIX GLOBAL INVESTMENT LIMITED, NO 3 JAMES WATTS ROAD BENIN 8035648967 generixglobalinvltd@gmail.com Popular Pharmaceuticals Ltd., 164 Tongi Industrial Area, Tongi, Gazipur-1711, Bangladeshi , Bangladesh | 25/05/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC Group | Classification | |
---|---|---|
G03DB01 | Dydrogesterone | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03D Progestogens → G03DB Pregnadien derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
NG | Registered Drug Product Database | A4-100399 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.